Enradin Tablet 4mg (Irsogladine Maleate)
Irsogladine Maleate 2mg
Tablet · Prescription medication
NBK Pharmaceutical Co., Ltd.
MFDS item code 202002040 · Approved 2020.03.24
This product's status changed to Approval withdrawn on 2024.07.08. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of gastric mucosal lesions (erosions, bleeding, etc.) in gastritis; treatment of gastric ulcers
This medication is primarily used in the treatment of gastric ulcers and helps improve gastric mucosal lesions (erosions, bleeding, redness, swelling) that occur during acute exacerbations of acute and chronic gastritis. Therefore, it is effective in protecting and improving the damage to the gastric mucosa.
Use for the following conditions as described below. Adjust the dose appropriately according to symptoms. 1) Gastric ulcer (Adults) Administer 4mg of irsogladine maleate orally once daily. 2) Improvement of gastric mucosal lesions (erosion, bleeding, redness, edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis (Adults) Administer 4mg of irsogladine maleate orally in 1∼2 divided doses daily.
This medication contains lactose, so individuals with genetic disorders that prevent lactose digestion should not take it. While taking this medication, side effects such as liver dysfunction, constipation, rash, itching, and diarrhea may occur, so caution should be exercised. Rarely reported side effects include dizziness, drowsiness, decreased appetite, and abdominal bloating; if any unusual symptoms occur, medical consultation should be sought immediately. The elderly may have decreased body function, so when taking this medication, it is advisable to start at a lower dosage and monitor their condition closely. Women who are pregnant or may become pregnant should only take this medication if the benefits outweigh the risks, as its safety during pregnancy is not established. Nursing mothers should avoid taking this medication as it can be transmitted through breast milk, or if taking it, should discontinue breastfeeding. Safety in children has not been established sufficiently, so it should be used cautiously in pediatric patients. This medication should be kept out of reach of children, and care should be taken not to transfer it to another container as this may affect the quality.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius to ensure the medication's efficacy.
White round tablet
For domestic use - 30 tablets/bottle, For domestic use - 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Irsogladine Maleate 2mg
Tablet · Prescription medication
NBK Pharmaceutical Co., Ltd.

Irsogladine Maleate 2mg
Tablet · Prescription medication
Taejun Pharmaceutical Co., Ltd.

Irsogladine Maleate 4mg
Tablet · Prescription medication
Taejun Pharmaceutical Co., Ltd.

Irsogladine Maleate 2mg
Orally disintegrating Tablet · Prescription medication
Taejun Pharmaceutical Co., Ltd.

Irsogladine Maleate 2mg
Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Irsogladine Maleate 2mg
Tablet · Prescription medication
Dong-gu Bio Pharmaceutical Co., Ltd.

Irsogladine Maleate 2mg
Tablet · Prescription medication
Ilyun Pharmaceutical Co., Ltd.

Irsogladine Maleate 4mg
Tablet · Prescription medication
(Co., Ltd.) Nexpharm Korea
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.